DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
批准号:
7605165
负责人:
THOMAS C MERIGAN
金额:
$2.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-15 至 2007-11-30
关键词:
AIDS clinical trial groupAdherenceAnti-Retroviral AgentsAzithromycinBacterial InfectionsCD4 Lymphocyte CountCardiovascular DiseasesCardiovascular systemCholesterolCognitiveCohort StudiesComputer Retrieval of Information on Scientific Projects DatabaseCoronary arteryDeteriorationDevelopmentEventFundingGrantHIVHighly Active Antiretroviral TherapyHip region structureImmunologicsImpaired cognitionInfectionInstitutionMyocardial InfarctionOpportunistic InfectionsParentsPatientsPharmaceutical PreparationsPlacebosPlasmaProceduresRNARateResearchResearch PersonnelResourcesRiskRisk FactorsSourceStrokeTimeTriglyceridesUnited States National Institutes of HealthViralcohortfollow-upimmunosuppressedinterestmortalitysudden cardiac death
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Primary
Determine the overall rates of and risk factors for AIDS-defining complications and serious bacterial infections in subjects in the parent study, ACTG 362.
Secondary
1. Determine the overall rates and risk factors (e.g. triglycerides,cholesterol, waist-to-hip ratio) for the development of cardiovascular disease in the study cohort. Cardiovascular events of interest include: myocardial infarction, coronary artery revascularization procedures, angina, sudden cardiac death, and stroke.
2. Compare the time to development of AIDS-defining complications and
serious infections or cardiovascular disease in subjects who were assigned
to receive Azithromycin to those who were assigned to receive placebo.
3. Evaluate the association between CD4 counts and HIV RNA levels at
baseline and during follow-up and risk of opportunistic infections and other
HIV-related complications.
4. Compare mortality in subjects who were assigned to receive Azithromycin to those who were assigned to receive placebo.
5. Define the risk of cognitive deterioration in a cohort of patients who
have been severely immunosuppressed and recovered CD4 counts while taking
Highly Active Antiretroviral Therapy (HAART).
6. Identify immunologic (CD4 counts) and virologic (plasma HIV RNA
levels) markers and specific drugs (especially PIs) associated with
cognitive decline.
7. Evaluate factors associated with long-term adherence to antiretroviral
medications and the effect of adherence on viral suppression over time and
on the development of opportunistic and serious bacterial infections and
cardiovascular diseas
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7605200
-
项目类别:
-
资助金额:$4.74万
-
财政年份:2007
-
负责人:THOMAS C MERIGAN
-
依托单位:
A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY
-
批准号:7605184
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2007
-
负责人:THOMAS C MERIGAN
-
依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7375261
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH DECREASED BONE MINERAL DENSITY RECEIVING CALCIUM AND VITAMIN D
-
批准号:7375239
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7375194
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
STUDY ON ABILITY TO ENHANCE HIV-SPECIFIC IMMUNE RESPONSES
-
批准号:7375233
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
ACTG 5001 ADULT AIDS CLINICAL TRIALS GROUP LONGITUDINAL LINKED RANDOMIZED
-
批准号:7202022
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
VIROLOGIC STUDIES IN COMPARTMENTAL SAMPLES FROM HIV-INFECTED SUBJECTS
-
批准号:7202038
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
PROTEASE INHIBITOR-SPARING REGIMENS FOR THE INITIAL TREATMENT OF HIV INFECTION
-
批准号:7202039
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
RIBAVIRIN ON ZIDOVUDINE OR STAVUDINE TRIPHOSPHATE FORMATION A5092S IN AIDS
-
批准号:7202053
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
TRIAL OF VALGANCICLOVIR ACTG 5030 AIDS STUDY
-
批准号:7202032
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
TREATMENT OF ELEVATED NON-HDL CHOLESTEROL AND ELEVATED TRIGLYCERIDES IN HIV
-
批准号:7202065
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
PULSE THERAPY ON THE CHARACTERISTICS OF TREATMENT INTERRUPTIONS AIDS
-
批准号:7202042
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
GENE CONSTRUCT IN THE TREATMENT OF PATIENTS WITH HIV-1 INFECTION
-
批准号:7202052
-
项目类别:
-
资助金额:$9.08万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7202023
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
STUDY ON ABILITY TO ENHANCE HIV-SPECIFIC IMMUNE RESPONSES
-
批准号:7202080
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH DECREASED BONE MINERAL DENSITY RECEIVING CALCIUM AND VITAMIN D
-
批准号:7202085
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7202114
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH FAILURE OF PREVIOUS PROTEASE INHIBITOR-BASED REGIMENS
-
批准号:7202075
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
A5132 AN EXPLORATORY, OPEN-LABEL, RANDOMIZED TRIAL
-
批准号:6980971
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2003
-
负责人:THOMAS C MERIGAN
-
依托单位:
海外基金